Powerock Pharma ALARELIN 5 mg
Powerock Pharma delivers reliability and pure Alarelin, which effectively stimulates the pituitary to release LH and FSH hormones in order to stimulate natural testosterone synthesis and regenerate the HPTA axis, supporting research on restoring hormonal homeostasis after periods of suppression.
ALARELIN 5 mg
ALARELIN is a synthetic nonapeptide and a potent Gonadotropin-Releasing Hormone (GnRH) agonist, intended exclusively for research purposes. This compound was designed for advanced research on the Hypothalamic-Pituitary-Gonadal (HPTA) axis. Its mechanism of action relies on stimulating the pituitary gland to release gonadotropic hormones (LH and FSH), which is crucial in analyzing hormonal system regeneration processes. This unique property makes Alarelin widely applicable in research regarding the restoration of natural testosterone production and fertility under laboratory conditions.
Alarelin Powerock Pharma - Properties
Discover the potential laboratory properties of the Alarelin peptide that can support research on endocrine system regeneration, sex hormone synthesis, and organism homeostasis.
HPTA Axis Regeneration
Enables the study of processes restoring natural hormonal pulsation after periods of suppression (PCT).
LH and FSH Stimulation
Effectively stimulates the pituitary to release Luteinizing Hormone and Follicle-Stimulating Hormone.
Testosterone Synthesis
Supports research on mechanisms of endogenous testosterone production in the gonads.
Homeostasis Support
Optimizes hormonal parameters in research focused on endocrine balance.
High Potency
Exhibits significantly stronger and longer-lasting effects than natural GnRH in research models.
Precise Action
Selective GnRH receptor agonism allows for accurate modulation of hormonal signals.
High Purity
≥98% purity confirmed by HPLC method to ensure result reliability.
Research Quality
Manufactured according to GMP, HACCP, and ISO 13485 standards exclusively for laboratory purposes.
How Alarelin works in a research environment
- GnRH Agonist: Alarelin binds to receptors in the pituitary gland, mimicking the action of natural gonadotropin-releasing hormone.
- Gonadotropin Release: Induces a potent release of LH (Luteinizing Hormone) and FSH (Follicle-Stimulating Hormone).
- Gonad Activation: Elevated LH levels stimulate Leydig cells in the testes to produce testosterone (in male models).
- Cycle Regulation: Influences follicle maturation and ovulation (in female models).
- Regenerative Research: Allows for the analysis of hormonal system "restart" blocked by external factors (e.g., anabolic agents).
Why choose Alarelin from Powerock Pharma?
At Powerock Pharma, our priority is to provide only the highest quality chemical reagents. Every batch of Alarelin is manufactured in laboratories compliant with GMP, HACCP, and ISO 13485 standards. Our strict quality control supervision and use of state-of-the-art testing procedures ensure not only research effectiveness but also the chemical stability of the substance. Collaboration with leading laboratories to ensure ≥98% purity (HPLC) guarantees consistent and repeatable experimental results. By choosing Powerock Pharma, you are opting for precision, procedural safety, and unparalleled quality of research materials.
Research Protocol
How to research:
Alarelin is supplied as a lyophilisate. It requires reconstitution with bacteriostatic water. Application in laboratory conditions is typically performed via the subcutaneous (s.c.) route using precise measuring tools.
When to administer:
To obtain optimal result reliability, administration should occur according to the circadian rhythm of the test subject (usually in the morning) or strictly according to the experiment design.
Cycle duration:
The recommended research cycle is typically 10–30 days. Short cycles allow for stimulation without the risk of permanent pituitary receptor desensitization.
Recommended amount for Model A (Ovulation Induction):
In studies on Model A, the initial dose is highly specific and usually falls within the range of 50–100 mcg (micrograms), adjusted to estradiol levels.
Recommended amount for Model B (Testosterone Stimulation):
For Model B, the standard research dose is 100–200 mcg daily. The amount of substance may be modified depending on the observed LH levels in the blood.
Monitoring:
Continuous monitoring of hormone levels (LH, FSH, Testosterone) in samples is essential. The HPTA axis response must be recorded to avoid overstimulation.
Frequently Asked Questions
- Dosage depends on the research objective but typically falls within the 50–200 mcg daily range. The vial contains 5 mg of substance, requiring precise solution division.
- Yes, in regenerative studies, Alarelin is often combined with BPC-157 (tissue regeneration) or HCG (LH mimicry) to achieve synergistic effects in restoring homeostasis.
- Local reactions at the injection site may occur. Hormonal changes may induce transient body temperature fluctuations (hot flashes) in test subjects.
- Short-term cycles are recommended. Long-term, continuous administration may lead to receptor desensitization and a counterproductive effect (decrease in hormone production).
- The lyophilisate should be stored at 2–8°C. After reconstitution, the solution must remain refrigerated and be used within 3-4 weeks.
- Our products are manufactured according to GMP and ISO 13485 standards. Purity ≥98% (HPLC) guarantees no impurities that could affect the experiment outcome.
Calculator for measuring research doses
Tip: 1 MG = 1000 MCG
